InvestorsHub Logo

DaubersUP

10/19/18 5:02 PM

#245582 RE: xoc #245580

It doesn’t make sense. But I’m old enough to have experienced these types of situations. Nothing this severe, but close. If Leo drops news of 10-20-90-300 million deal with hundreds of millions in milestones for IBD and OM....we will find out fast just why this stock price is here.

I want to see that squeeze!!!!

It’s not like we diluted to billions and should be here. A simple 20 million increase over the year does not warrant this. IMO. At all.

frrol

10/19/18 6:23 PM

#245593 RE: xoc #245580

As the stock price drops, our shares o/s potentially skyrockets. I suspect most people don't understand the MFO sale. It will go up a minimum of about 30MM shares, and that is only if the share price didn't fall and the MFO doesn't convert. We have an authorized limit of 300 million shares, but Leo would be forced to increase that if they do convert at these prices (we'd get sued otherwise). That MFO share sale only does us good if we get some good news soon and the share price stays up. The price isn't cooperating. It's a market and most out there think we're failing to deliver. Can you see why they might?

The company is doing what it can. It has a deal term sheet. It submitted a BTD application and arranged for an FDA meeting. It got more stop-gap financing. It lined up our B suppliers for the next trials. It plans to attend an IBD conference in Nov. The lights are still "on", they're just really dim because of financing mistakes and avoidable delays. Hang in there if you can, folks. Don't listen to anyone calling bottom with their sophisticated chart "TA", I think we all understand what that's worth by now. And don't listen to anyone pumping about $30 share prices and drugs worth billions. They are conspicuously unqualified and can mislead you.